RxDoctor Payments Data

Logan Walker, DO

Internal Medicine · Grand Haven, MINPI 1114300928

Payments from drug & device makers

$1,546in general payments, 2019–2025

Across 84 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$345
  • Novo Nordisk$344
  • AbbVie$210
  • GSK$109
  • Abbott$95
  • AstraZeneca$89
  • plus $354 from 12 others

What the payments were for

  • Food & beverage$1,49497%
  • Education$533%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,546 in reported general payments places this provider in the 75th percentile of 4,567 internal medicine providers in Michigan.

See all internal medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$85,557
Medicare patients
246
Services billed
5,320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban223$278,498
JardianceEmpagliflozin123$138,586
MounjaroTirzepatide100$125,694
TrulicityDulaglutide42$66,924
FarxigaDapagliflozin Propanediol45$58,235
OzempicSemaglutide30$55,708
XareltoRivaroxaban50$50,389
Atorvastatin Calcium900$17,364
LinzessLinaclotide15$16,820
JanuviaSitagliptin Phosphate19$15,798
MyrbetriqMirabegron13$10,535
Omeprazole330$7,728
Metoprolol Succinate320$7,331
Levothyroxine Sodium428$7,313
Tamsulosin Hcl288$6,934

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$345$278,498223 claims
Lilly USA, LLCMounjaro, Trulicity$28$192,619142 claims
Boehringer IngelheimJardiance$66$138,586123 claims
AstraZenecaFarxiga$89$58,23545 claims
Novo NordiskOzempic$344$55,70830 claims
Johnson & JohnsonXarelto$11$50,38950 claims
AbbVieLinzess, Synthroid$210$19,16839 claims
GSKAnoro Ellipta$109$5,78311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,567 internal medicine providers in Michigan.

Other internal medicine in Grand Haven

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →